MedTrace Logo

Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II

NCT00762086 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2012-08-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of new intermittent pneumatic compression device on initial claudication distance in patients with Peripheral Arterial Disease stage II

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

AngioPress Intermittent pneumatic compression (IPC) Device

Treatment with Intermittent pneumatic compression (IPC) for PAD

OTHER

Medications and Standard walking exercises

Aspirin/Clopidegrol and Standard walking exercises

Sponsors & Collaborators

  • Mego Afek Ltd.

    lead INDUSTRY

Principal Investigators

  • Avigdor Zelikovski, Prof.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762086 on ClinicalTrials.gov